Participating Faculty: Practical Perspectives on the Management of Overweight and Obesity

March 18, 2014
Robert S. Gregory, RPh, MS, MBA

,
Yehuda Handelsman, MD, FACP, FACE, FNLA

,
Edmund J. Pezalla, MD, MPH

,
Dan Pikelny, MA, MBA

Supplements and Featured Publications, Practical Perspectives on the Management of Overweight and Obesity, Volume 20, Issue 3 Suppl

This supplement to The American Journal of Managed Care summarizes proceedings from a roundtable meeting that was conducted to discuss the management of obesity in the workplace, healthcare, and managed care settings; managed care coverage policies for obesity treatments; and potential strategies for improving patient outcomes.This supplement was supported by VIVUS, INC.

Faculty

Robert S. Gregory, RPh, MS, MBA—Moderator

President

Rx Gregory Consulting, LLC

Johns Island, South Carolina

Yehuda Handelsman, MD, FACP, FACE, FNLA

Medical Director and Principal Investigator

Metabolic Institute of America

Tarzana, California

Chair and Program Director

12th Annual World Congress on Insulin Resistance

Universal City, California

Edmund J. Pezalla, MD, MPH

Vice President

National Medical Director

Pharmaceutical Policy and Strategy

Office of the Chief Medical Officer

Aetna

Hartford, Connecticut

Dan Pikelny, MA, MBA

Director

Compensation, Benefits, and Health

Navistar, Inc

Lisle, Illinois

Faculty Disclosures

These faculty report relationships with the following organizations:

Robert S. Gregory, RPh, MS, MBA—Moderator

Consultant/paid advisory board: Vivus, Inc

Yehuda Handelsman, MD, FACP, FACE, FNLA

Consultant: Amarin, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Inc, diaDexus, Eisai, Gilead, GlaxoSmithKline, Halozyme, Janssen, LipoScience, Merck, Novo Nordisk, Sanofi, Santarus, Vivus, Inc

Research grants: Amgen, Boehringer Ingelheim, Gilead, GlaxoSmithKline, Intarcia, Lexicon, Merck, Novo Nordisk, Sanofi, Takeda

Speakers bureau: Amarin, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Inc, GlaxoSmithKline, Janssen, Lilly, Novo Nordisk, Santarus, Vivus, Inc

Dan Pikelny, MA, MBA

Lecture fees/meeting attendance: Vivus, Inc

Edmund J. Pezalla, MD, MPH, reports no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this supplement.

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.

Related Content:

Publications